Article info
Uterine Cancer
The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible
- Address correspondence and reprint requests to Eugenia Girda, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UC Davis Medical Center, 4860 Y St, Suite 2500, Sacramento, CA 95817. E-mail: egirda@ucdavis.edu.
Citation
The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible
Publication history
- Received February 10, 2017
- First published October 1, 2017.
Online issue publication
October 01, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of IGCS and ESGO.